Serum PAPP-A and uterine artery Doppler as predictors of preeclampsia
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20262098Keywords:
Serum PAPP-A, Uterine artery doppler, PreeclampsiaAbstract
Background: Preeclampsia (PE) is a disorder that happens during pregnancy. It is marked primarily by symptoms such as high blood pressure and problems with organs that develop after 20 weeks of gestation. Recently, biomarkers like pregnancy-associated plasma protein A (PAPP-A) and uterine artery Doppler pulsatility index (PI) have been identified as new predictors of PE because they reflect the condition and throughput of the placenta. Therefore, the goal of this research was to determine how accurate maternal serum PAPP-A levels and uterine artery PI predict PE when used not only separately but also together.
Methods: This prospective cohort study was carried out in Department of Obstetrics and Gynecology and the Fetal-Maternal Medicine Department of Bangladesh Medical University (BMU) Dhaka during January 2024 to December 2024. The sample of the study consisted of 99 pregnant women who visited outpatient departments, their gestational age was between 12 and 20 weeks and they were normotensive. Statistical analysis was done through SPSS version 26.0. The association between PAPP-A levels and the development of PE, which was illustrated through odds ratios (ORs) with 95% confidence intervals (CIs), and a p-value less than 0.05 was regarded as statistically significant.
Results: ROC analysis showed that PAPP-A has moderate predictive ability for preeclampsia, with an AUC of 0.742 (95% CI:0.638-0.846, p=0.03). A cut-off value of ≥0.55 yielded good sensitivity (72.73-81.82%) and moderate specificity (68.18%), with a high negative predictive value (95.24-95.28%) but low positive predictive value (22.22%) and overall accuracy of 68.69%. Most PE cases (8 of 11) occurred in participants with PAPP-A <0.55, supporting its role as a predictor. Similarly, elevated uterine artery PI (≥1.61) was observed in 7 of 11 PE cases and showed high specificity (93.18%), high negative predictive value (95.35%), moderate sensitivity (63.64%), and overall accuracy of 89.90%, indicating a strong association between increased PI and the development of preeclampsia.
Conclusions: Low PAPP-A and high uterine artery PI show solid early signs of preeclampsia. Tracking these markers in first trimester pregnancies helps spot at-risk women. Early detection allows actions to be taken before complications arise. Interventions can reduce harm to mother and baby. The data supports real-time risk assessment without waiting for symptoms to appear.
References
Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24-43.
Bersinger NA, Smárason AK, Muttukrishna S, Groome NP, Redman CW. Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A, and soluble E-selectin. Hypertens Pregnancy. 2003;22(1):45-55.
Anderson UD, Olsson MG, Kristensen KH, Åkerström B, Hansson SR. Biochemical markers to predict preeclampsia. Placenta. 2012;33:S42-7.
Chantanavilai S, Kongwattanakul K, Komwilaisak R, Saksiriwuttho P, Chaiyarach S, Duangkam C, et al. Epidemiology and prognostic factors for successful expectant management of early-onset severe features preeclampsia: A retrospective multicenter cohort study. Pregnancy Hypertens. 2022;30:226-31.
Kuc S, Wortelboer EJ, Van Rijn BB, Franx A, Visser GH, Schielen PC. Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv. 2011;66(4):225-39.
Movahedi M, Khanjani S, Shahshahan Z, Hajihashemi M, Farahbod F, Shahsavandi E. Evaluation of the relationship between pregnancy-associated plasma protein A (PAPP-A) and pregnancy outcomes. Adv Biomed Res. 2023;12(1):91.
Oancea MD, Costin N, Pop DM, Ciortea R, Mihu D. Evaluation of serum β-hCG and PAPP-A levels in pregnant women at risk of developing preeclampsia. Clujul Med. 2013;86(4):347-50.
Mou AD, Barman Z, Hasan M, Miah R, Hafsa JM, Das Trisha A, et al. Prevalence of preeclampsia and the associated risk factors among pregnant women in Bangladesh. Sci Rep. 2021;11(1):21339.
Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol. 2010;5(1):173-92.
Poidatz D, Dos Santos E, Duval F, Moindjie H, Serazin V, Vialard F, et al. Involvement of estrogen-related receptor-γ and mitochondrial content in intrauterine growth restriction and preeclampsia. Fertil steril. 2015;104(2):483-90.
Bilodeau JF. maternal and placental antioxidant response to preeclampsia–impact on vasoactive eicosanoids. Placenta. 2014;35:S32-8.
Lakshmy SR, Praveenkumar M, Shobana U, Thasleem Z. Uterine artery Doppler: changing concepts in prediction and prevention of PE and FGR. J Fetal Med. 2018;5(2):93-105.
Mönckeberg M, Arias V, Fuenzalida R, Álvarez S, Toro V, Calvo A, et al. Diagnostic performance of first trimester screening of preeclampsia based on uterine artery pulsatility index and maternal risk factors in routine clinical use. Diagnostics (Basel). 2020;10(4):182.
Moslemi Zadeh N, Naghshvar F, Peyvandi S, Gheshlaghi P, Ehetshami S. PP13 and PAPP-A in the first and second trimesters: predictive factors for preeclampsia?. ISRN Obstet Gynecol. 2012;2012:263871.
Yu W, Gao W, Rong D, Wu Z, Khalil RA. Molecular determinants of microvascular dysfunction in hypertensive pregnancy and preeclampsia. Microcirculation. 2019;26(4):e12508.
Townsend R, Khalil A, Premakumar Y, Allotey J, Snell KI, Chan C, Chappell LC, et al. Prediction of pre-eclampsia: review of reviews. Ultrasound Obstet Gynecol. 2019;54(1):16-27.
Das E, Singh V, Agrawal S, Pati SK. Prediction of preeclampsia using first-trimester uterine artery Doppler and pregnancy-associated plasma protein A (PAPP-A): a prospective study in Chhattisgarh, India. Cureus. 2022;14(2):e22107.
Yücel B, Gedikbasi A, Dündar O, Olgac Y, Yıldırım D, Yıldırım G, et al. The utility of first trimester uterine artery Doppler, placental volume and PAPP-A levels alone and in combination to predict preeclampsia. Pregnancy Hypertens. 2016;6(4):269-73.
Köpük ŞY, Çakıroğlu Y, Ceylan Y, Çekmen MB, Yücesoy G. Prediction of preeclampsia by uterine artery Doppler examination and placental growth factor, endoglin and pregnancy-associated plasma protein levels in maternal serum at 11–13+6 weeks of pregnancy. Eur Arch Med Res. 2019;35(3):137.
Spencer K, Yu CK, Cowans NJ, Otigbah C, Nicolaides KH. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free β-hCG and with second-trimester uterine artery Doppler. Prenat Diagn. 2005;25(10):949-53.
Kenny LC, Black MA, Poston L, Taylor R, Myers JE, Baker PN, et al. Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the Screening for Pregnancy Endpoints (SCOPE) international cohort study. Hypertension. 2014;64(3):644-52.
Wu P, Van den Berg C, Alfirevic Z, O’Brien S, Röthlisberger M, Baker PN, et al. Early pregnancy biomarkers in pre-eclampsia: a systematic review and meta-analysis. Int J Mol Sci. 2015;16(9):23035-56.
Downloads
Published
How to Cite
Issue
Section
